The statistic displays the quarterly share of Celltrion's Truxima in the European market from the second quarter of 2017 to the second quarter of 2018. As of Q2 2018, the Truxima products from South Korean biopharmaceutical company Celltrion took up around 32 percent within the European market, increased from 27 percent in the previous quarter.
Quarterly share of Celltrion's Truxima in the European market from 2nd quarter 2017 to 2nd quarter 2018
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Spain
Main figures
6
- Basic Statistic Production value of pharmaceutical products & preparations in Spain 2009-2020
- Basic Statistic Turnover of the manufacture of pharmaceutical products in Spain 2009-2020
- Basic Statistic Workers in the Spanish pharmaceutical industry 2008-2020
- Premium Statistic Wages earned in the pharmaceutical industry sector in Spain 2008-2020
- Basic Statistic Spain: number of manufacturers of basic pharmaceutical products 2009-2020
- Basic Statistic Spain: number of pharmaceutical preparations manufacturers 2009-2020
International trade
6
- Premium Statistic Value of pharmaceutical products exported from Spain 2002-2021
- Premium Statistic Value of pharmaceutical products imported by Spain 2002-2021
- Premium Statistic Export value of pharmaceutical products in Spain 2021, by type
- Premium Statistic Import value of pharmaceutical products in Spain 2021, by type
- Premium Statistic Pharmaceutical products export value in Spain 2021, by country of destination
- Premium Statistic Import value of pharmaceutical products in Spain 2021, by country
Pharmaceutical sales
6
- Premium Statistic Net sales of drugs in pharmacies in Spain 2012-2021
- Premium Statistic Net value of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Value share of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Volume of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Volume share of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Average price of drugs sold in pharmacies by therapeutic group in Spain 2021
Pharmaceutical expenditure of the National Health System
6
- Premium Statistic Budget expenditure on health benefits & pharmacy in Spain 2003-2022
- Premium Statistic NHS expenditure on prescribed medicines in pharmacies in Spain 2010-2021
- Premium Statistic Average cost of medical prescriptions in pharmacies in Spain 2010-2021
- Premium Statistic State-funded drug prescriptions dispensed in pharmacies in Spain 2010-2021
- Premium Statistic NHS expenditure per prescription dispensed in pharmacies in Spain 2021, by region
- Premium Statistic Share of per capita pharmaceutical expenditure in Spain 2021, by region
Research and development
6
- Premium Statistic Share of total R&D spending in Spain in 2020, by industrial sector
- Premium Statistic R&D expenditure in the pharmaceutical industry in Spain 2008-2021
- Premium Statistic R&D employment within the pharmaceutical industry in Spain 2008-2021
- Premium Statistic Pharmaceutical R&D spending by type Spain 2021
- Premium Statistic Internal and external R&D expenditure in the pharmaceutical industry Spain 2013-2021
- Premium Statistic External R&D expenditure in the pharmaceutical industry by region Spain 2021
Company rankings
6
- Premium Statistic Leading basic pharmaceutical products manufacturers in Spain in 2020
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2020
- Premium Statistic Leading pharmaceutical goods wholesalers in Spain in 2020
- Premium Statistic Corporate reputation of leading pharmaceutical companies in Spain in 2022
- Premium Statistic Sales value of the largest-selling prescription drugs in Spain 2020
- Premium Statistic Sales volume of the largest-selling prescription drugs in Spain 2019-2020
Further related statistics
20
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Celltrion R&D investment South Korea 2013-2017
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Biopharmaceuticals revenue in Latin America 2022-2027
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Trade balance in high technology sectors of EU countries 2021
- Revenue forecast for global biologics market 2016-2022
- Worldwide biopharma M&A transaction volume by location 2015-2019
- Loss of Neupogen sales to U.S. biosimilars 2015-2017
- Loss of Lantus sales to U.S. biosimilars 2015-2017
- Breakdown of transport modes in biopharma cold chain logistics 2019
- Global biopharma non-cold chain product sales 2016-2024
- Priorities of life sciences logistics leaders in biopharma cold chain logistics 2019
- Average temperature of excursion shipments in biopharma cold chain logistics 2019
- Global biopharma logistics spending breakdown by type 2019
- Italy: average prices of biosimilars and originators 2016-2017
- Italy: market value of biopharmaceuticals 2017, by type
- Italy: estimated market value of biosimilars 2018-2022, by type
- Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase
Further Content: You might find this interesting as well
Statistics
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Celltrion R&D investment South Korea 2013-2017
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Biopharmaceuticals revenue in Latin America 2022-2027
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Trade balance in high technology sectors of EU countries 2021
- Revenue forecast for global biologics market 2016-2022
- Worldwide biopharma M&A transaction volume by location 2015-2019
- Loss of Neupogen sales to U.S. biosimilars 2015-2017
- Loss of Lantus sales to U.S. biosimilars 2015-2017
- Breakdown of transport modes in biopharma cold chain logistics 2019
- Global biopharma non-cold chain product sales 2016-2024
- Priorities of life sciences logistics leaders in biopharma cold chain logistics 2019
- Average temperature of excursion shipments in biopharma cold chain logistics 2019
- Global biopharma logistics spending breakdown by type 2019
- Italy: average prices of biosimilars and originators 2016-2017
- Italy: market value of biopharmaceuticals 2017, by type
- Italy: estimated market value of biosimilars 2018-2022, by type
- Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase
Mirae Asset. (December 5, 2018). Quarterly share of Celltrion's Truxima in the European market from 2nd quarter 2017 to 2nd quarter 2018 [Graph]. In Statista. Retrieved March 29, 2023, from https://www.statista.com/statistics/1000643/south-korea-celltrion-truxima-market-share-in-europe/
Mirae Asset. "Quarterly share of Celltrion's Truxima in the European market from 2nd quarter 2017 to 2nd quarter 2018 ." Chart. December 5, 2018. Statista. Accessed March 29, 2023. https://www.statista.com/statistics/1000643/south-korea-celltrion-truxima-market-share-in-europe/
Mirae Asset. (2018). Quarterly share of Celltrion's Truxima in the European market from 2nd quarter 2017 to 2nd quarter 2018 . Statista. Statista Inc.. Accessed: March 29, 2023. https://www.statista.com/statistics/1000643/south-korea-celltrion-truxima-market-share-in-europe/
Mirae Asset. "Quarterly Share of Celltrion's Truxima in The European Market from 2nd Quarter 2017 to 2nd Quarter 2018 ." Statista, Statista Inc., 5 Dec 2018, https://www.statista.com/statistics/1000643/south-korea-celltrion-truxima-market-share-in-europe/
Mirae Asset, Quarterly share of Celltrion's Truxima in the European market from 2nd quarter 2017 to 2nd quarter 2018 Statista, https://www.statista.com/statistics/1000643/south-korea-celltrion-truxima-market-share-in-europe/ (last visited March 29, 2023)
Quarterly share of Celltrion's Truxima in the European market from 2nd quarter 2017 to 2nd quarter 2018 [Graph], Mirae Asset, December 5, 2018. [Online]. Available: https://www.statista.com/statistics/1000643/south-korea-celltrion-truxima-market-share-in-europe/